Formulation Development
  • QbD-based product development for Parenteral dosage form (Liquids, Lyophilized, Liposomal, Suspension, and Emulsion), Topical dosage form,Ophthalmic dosage form and Nasal dosage form.
  • Designing drug products with 505 b(2) strategy within acceptable regulatory and proprietary limitations.
  • Customizable services based on Client needs (Product development to Commercial supply)
  • Dedicative project execution experts for each client to support product development
Nasal Solutions
Nasal Solutions
  • Solutions
Topicals Skincare
Topicals Skincare
  • Emulsion (O/W and W/O emulsion based)
  • Ointment
orals-liquid
orals-liquid
  • Solutions
  • Syrups
  • Suspension
Formulations
Formulations
  • Depot Suspension Injections
  • Nano-Emulsions
  • Protein & Peptide injections
  • Drug Device combinations
  • NCE-1 and 505 (b) 2 strategies
Sterlin Labs Logo
Sterlin Labs Private Limited
We believe that any innovation starts with a challenge or unusual idea, however each challenge or idea is worthwhile to be explored.
About Us
Let’s make something great together
Get in touch with us and send some basic info for a quick quote